The potential of computational chemistry to revolutionise cancer treatment in Nigeria represents a paradigm shift in medical ...

CytomX Therapeutics, Inc.’s CTMX share price has surged by 5.56%, which has investors questioning if this is right time to ...

The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...

Aurobindo Pharma's biosimilar for breast cancer recommended for EU approval, demonstrating similarity to Herceptin.

Used for treatment of HER2-positive metastatic and early breast cancers ...

Hyderabad: CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Limited, has announced that the ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Janux Therapeutics, Inc.’s JANX share price has dipped by 5.83%, which has investors questioning if this is right time to buy.

Dizal will also present results from the ongoing Phase I/II study of DZD6008, a 4th generation EGFR TKI with full BBB penetration, in advanced EGFR mutation positive (EGFRm) non-small cell lung cancer ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

The key role nanodomains play in regulating the activity of the epidermal growth factor receptor (EGFR)—a protein ... "The PI(4,5)P 2 nanodomain supports EGFR activation, while activated EGFR ...